Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose rifampicin in children with tuberculosis
NCT04437836Phase 2Completed
- Sponsor
- Kilimanjaro Clinical Research Institute
- Start
- Jul 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifampicin in Tuberculosis (TB), sponsored by Kilimanjaro Clinical Research Institute. Started Jul 2019; status: completed.
02
Drugs
rifampicin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT04437836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04437836.